{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:38:15Z","timestamp":1783442295919,"version":"3.54.6"},"publisher-location":"Cham","reference-count":101,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030590376","type":"print"},{"value":"9783030590383","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-59038-3_7","type":"book-chapter","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:06:56Z","timestamp":1624979216000},"page":"117-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Pituitary Tumors and Their Tumor-Specific Microenvironment"],"prefix":"10.1007","author":[{"given":"M. M.","family":"Kameda-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. -Q.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"7_CR1","unstructured":"Asa SL (2000) Pituitary Histopathology in Man: Normal and Abnormal. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al. (ed) Endotext. South Dartmouth (MA)"},{"issue":"6230","key":"7_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348(6230):74\u201380","journal-title":"Science"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.copbio.2016.02.007","volume":"40","author":"F Spill","year":"2016","unstructured":"Spill F, Reynolds DS, Kamm RD, Zaman MH (2016) Impact of the physical microenvironment on tumor progression and metastasis. Curr Opin Biotechnol 40:41\u201348","journal-title":"Curr Opin Biotechnol"},{"issue":"18","key":"7_CR4","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates Cancer progression. Cancer Res 79(18):4557\u20134566","journal-title":"Cancer Res"},{"key":"7_CR5","doi-asserted-by":"crossref","unstructured":"Sato M, Tamura R, Tamura H, Mase T, Kosugi K, Morimoto Y et al (2019) Analysis of tumor angiogenesis and immune microenvironment in non-functional pituitary endocrine tumors. J Clin Med 8(5)","DOI":"10.3390\/jcm8050695"},{"issue":"11","key":"7_CR6","first-page":"4639","volume":"32","author":"A Sav","year":"2012","unstructured":"Sav A, Rotondo F, Syro LV, Scheithauer BW, Kovacs K (2012) Biomarkers of pituitary neoplasms. Anticancer Res 32(11):4639\u20134654","journal-title":"Anticancer Res"},{"key":"7_CR7","first-page":"26","volume-title":"Normal brain histopathology. practical surgical neuropathology: a diagnostic approach","author":"DJ Brat","year":"2010","unstructured":"Brat DJ (2010) Normal brain histopathology. practical surgical neuropathology: a diagnostic approach. Elsevier, Philadelphia, p 26"},{"key":"7_CR8","unstructured":"Beatriz M LS, Pernicone PJ, Scheithauer BW, Horvath E, Kovacs K. Pituitary and sellar region. In: SE M, editor. Histology for pathologists. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 343\u2013372"},{"issue":"6","key":"7_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2265.1993.tb02136.x","volume":"38","author":"A Levy","year":"1993","unstructured":"Levy A, Lightman SL (1993) The pathogenesis of pituitary adenomas. Clin Endocrinol 38(6):559\u2013570","journal-title":"Clin Endocrinol"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/B978-0-443-06982-6.00018-3","volume-title":"Practical surgical neuropathology: a diagnostic approach","author":"BW Scheithauer","year":"2010","unstructured":"Scheithauer BW, Kovacs K, Horvath E, Silva AI, Lloyd RV (2010) Pathology of the pituitary and sellar region. In: Perry A, Brat DJ (eds) Practical surgical neuropathology: a diagnostic approach. Elsevier, Philadelphia, pp 371\u2013416"},{"issue":"11","key":"7_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1593\/neo.08572","volume":"10","author":"R Ashkenazi","year":"2008","unstructured":"Ashkenazi R, Gentry SN, Jackson TL (2008) Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny. Neoplasia 10(11):1170\u20131182","journal-title":"Neoplasia"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13578-017-0188-9","volume":"7","author":"Y Cao","year":"2017","unstructured":"Cao Y (2017) Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor\/progenitor cells. Cell Biosci 7:61","journal-title":"Cell Biosci"},{"issue":"2","key":"7_CR13","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/JOE-18-0446","volume":"240","author":"S Pepe","year":"2019","unstructured":"Pepe S, Korbonits M, Iacovazzo D (2019) Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects. J Endocrinol 240(2):R21\u2013R45","journal-title":"J Endocrinol"},{"issue":"1","key":"7_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2007.10.009","volume":"37","author":"A Levy","year":"2008","unstructured":"Levy A (2008) Molecular and trophic mechanisms of tumorigenesis. Endocrinol Metab Clin N Am 37(1):23\u201350. vii","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"7_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.23907\/2016.023","volume":"6","author":"AR Wang","year":"2016","unstructured":"Wang AR, Gill JR (2016) The pituitary gland: an infrequent but multifaceted contributor to death. Acad Forensic Pathol 6(2):206\u2013216","journal-title":"Acad Forensic Pathol"},{"issue":"10","key":"7_CR16","first-page":"3455","volume":"81","author":"PU Freda","year":"1996","unstructured":"Freda PU, Wardlaw SL, Post KD (1996) Unusual causes of sellar\/parasellar masses in a large transsphenoidal surgical series. J Clin Endocrinol Metab 81(10):3455\u20133459","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2265.2010.03881.x","volume":"73","author":"E Valassi","year":"2010","unstructured":"Valassi E, Biller BM, Klibanski A, Swearingen B (2010) Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol 73(6):798\u2013807","journal-title":"Clin Endocrinol"},{"issue":"3","key":"7_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613\u2013619","journal-title":"Cancer"},{"issue":"2","key":"7_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11102-018-0863-9","volume":"21","author":"M Tampourlou","year":"2018","unstructured":"Tampourlou M, Fountas A, Ntali G, Karavitaki N (2018) Mortality in patients with non-functioning pituitary adenoma. Pituitary 21(2):203\u2013207","journal-title":"Pituitary"},{"issue":"3","key":"7_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243","journal-title":"Endocr Pathol"},{"issue":"5","key":"7_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.beem.2009.05.004","volume":"23","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Grossman AB (2009) The pathophysiology of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23(5):525\u2013541","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"7_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ecl.2014.11.001","volume":"44","author":"SE Mayson","year":"2015","unstructured":"Mayson SE, Snyder PJ (2015) Silent pituitary adenomas. Endocrinol Metab Clin N Am 44(1):79\u201387","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"4","key":"7_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000330857","volume":"94","author":"T Florio","year":"2011","unstructured":"Florio T (2011) Adult pituitary stem cells: from pituitary plasticity to adenoma development. Neuroendocrinology 94(4):265\u2013277","journal-title":"Neuroendocrinology"},{"issue":"3","key":"7_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/omi.2010.0091","volume":"15","author":"S Dinicola","year":"2011","unstructured":"Dinicola S, D'Anselmi F, Pasqualato A, Proietti S, Lisi E, Cucina A et al (2011) A systems biology approach to cancer: fractals, attractors, and nonlinear dynamics. OMICS 15(3):93\u2013104","journal-title":"OMICS"},{"issue":"6","key":"7_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ccell.2019.05.003","volume":"35","author":"P Chen","year":"2019","unstructured":"Chen P, Zhao D, Li J, Liang X, Li J, Chang A et al (2019) Symbiotic macrophage-glioma cell interactions reveal synthetic lethality in PTEN-null glioma. Cancer Cell 35(6):868\u2013884. e6","journal-title":"Cancer Cell"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1479-5876-12-71","volume":"12","author":"L Zhenye","year":"2014","unstructured":"Zhenye L, Chuzhong L, Youtu W, Xiaolei L, Lei C, Lichuan H et al (2014) The expression of TGF-beta1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas. J Transl Med 12:71","journal-title":"J Transl Med"},{"issue":"9","key":"7_CR27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/neuonc\/nou046","volume":"16","author":"Q Zheng","year":"2014","unstructured":"Zheng Q, Han L, Dong Y, Tian J, Huang W, Liu Z et al (2014) JAK2\/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII\/JAK2\/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Neuro-Oncology 16(9):1229\u20131243","journal-title":"Neuro-Oncology"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.mce.2016.07.025","volume":"436","author":"J Feng","year":"2016","unstructured":"Feng J, Yu SY, Li CZ, Li ZY, Zhang YZ (2016) Integrative proteomics and transcriptomics revealed that activation of the IL-6R\/JAK2\/STAT3\/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas. Mol Cell Endocrinol 436:195\u2013203","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"7_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1677\/ERC-08-0167","volume":"16","author":"Y Lin","year":"2009","unstructured":"Lin Y, Jiang X, Shen Y, Li M, Ma H, Xing M et al (2009) Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors. Endocr Relat Cancer 16(1):301\u2013310","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"7_CR30","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1172\/JCI32533","volume":"117","author":"P Sansone","year":"2007","unstructured":"Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M et al (2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117(12):3988\u20134002","journal-title":"J Clin Invest"},{"issue":"4","key":"7_CR31","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.3892\/mmr.2015.4050","volume":"12","author":"F Liu","year":"2015","unstructured":"Liu F, Zhang T, Zou S, Jiang B, Hua D (2015) B7H3 promotes cell migration and invasion through the Jak2\/Stat3\/MMP9 signaling pathway in colorectal cancer. Mol Med Rep 12(4):5455\u20135460","journal-title":"Mol Med Rep"},{"issue":"10","key":"7_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109114","volume":"9","author":"J Kowshik","year":"2014","unstructured":"Kowshik J, Baba AB, Giri H, Deepak Reddy G, Dixit M, Nagini S (2014) Astaxanthin inhibits JAK\/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer. PLoS One 9(10):e109114","journal-title":"PLoS One"},{"issue":"2","key":"7_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-012-9682-3","volume":"42","author":"H Rubinfeld","year":"2012","unstructured":"Rubinfeld H, Shimon I (2012) PI3K\/Akt\/mTOR and Raf\/MEK\/ERK signaling pathways perturbations in non-functioning pituitary adenomas. Endocrine 42(2):285\u2013291","journal-title":"Endocrine"},{"issue":"37","key":"7_CR34","doi-asserted-by":"publisher","first-page":"12950","DOI":"10.1523\/JNEUROSCI.2017-12.2012","volume":"32","author":"S Scully","year":"2012","unstructured":"Scully S, Francescone R, Faibish M, Bentley B, Taylor SL, Oh D et al (2012) Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci 32(37):12950\u201312960","journal-title":"J Neurosci"},{"issue":"4","key":"7_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12253-017-0196-4","volume":"23","author":"J Di Michele","year":"2017","unstructured":"Di Michele J, Rotondo F, Kovacs K, Syro LV, Yousef GM, Cusimano MD et al (2017) Vasculogenic mimicry in clinically non-functioning pituitary adenomas: a histologic study. Pathol Oncol Res 23(4):803\u2013809","journal-title":"Pathol Oncol Res"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fonc.2019.00803","volume":"9","author":"M Fernandez-Cortes","year":"2019","unstructured":"Fernandez-Cortes M, Delgado-Bellido D, Oliver FJ (2019) Vasculogenic mimicry: become an endothelial cell \u201cbut not so much\u201d. Front Oncol 9:803","journal-title":"Front Oncol"},{"issue":"18","key":"7_CR37","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1016\/j.ejca.2013.07.148","volume":"49","author":"Z Cao","year":"2013","unstructured":"Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q (2013) Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer 49(18):3914\u20133923","journal-title":"Eur J Cancer"},{"issue":"1","key":"7_CR38","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1152\/ajpcell.00084.2014","volume":"307","author":"A Birbrair","year":"2014","unstructured":"Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A et al (2014) Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol 307(1):C25\u2013C38","journal-title":"Am J Physiol Cell Physiol"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-030-16908-4_5","volume":"1147","author":"Z Pieterse","year":"2019","unstructured":"Pieterse Z, Sinha D, Kaur P (2019) Pericytes in metastasis. Adv Exp Med Biol 1147:125\u2013135","journal-title":"Adv Exp Med Biol"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-030-16908-4_2","volume":"1147","author":"A Sattiraju","year":"2019","unstructured":"Sattiraju A, Mintz A (2019) Pericytes in glioblastomas: multifaceted role within tumor microenvironments and potential for therapeutic interventions. Adv Exp Med Biol 1147:65\u201391","journal-title":"Adv Exp Med Biol"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mvr.2013.04.009","volume":"89","author":"A Di Ieva","year":"2013","unstructured":"Di Ieva A, Weckman A, Di Michele J, Rotondo F, Grizzi F, Kovacs K et al (2013) Microvascular morphometrics of the hypophysis and pituitary tumors: from bench to operating theatre. Microvasc Res 89:7\u201314","journal-title":"Microvasc Res"},{"issue":"2","key":"7_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11102-015-0698-6","volume":"19","author":"Y Miao","year":"2016","unstructured":"Miao Y, Zong M, Jiang T, Yuan X, Guan S, Wang Y et al (2016) A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34\/CD105) expression on pituitary adenoma invasion. Pituitary 19(2):194\u2013201","journal-title":"Pituitary"},{"issue":"11","key":"7_CR43","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/01.LAB.0000098429.59348.36","volume":"83","author":"G Cosio","year":"2003","unstructured":"Cosio G, Jeziorski MC, Lopez-Barrera F, De La Escalera GM, Clapp C (2003) Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary adenoma cell line. Lab Investig 83(11):1627\u20131636","journal-title":"Lab Investig"},{"issue":"4","key":"7_CR44","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1073\/pnas.96.4.1246","volume":"96","author":"I Struman","year":"1999","unstructured":"Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V et al (1999) Opposing actions of intact and N-terminal fragments of the human prolactin\/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A 96(4):1246\u20131251","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fendo.2019.00007","volume":"10","author":"Q Yang","year":"2019","unstructured":"Yang Q, Li X (2019) Molecular network basis of invasive pituitary adenoma: a review. Front Endocrinol (Lausanne) 10:7","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"7_CR46","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01420300","volume":"138","author":"H Kawamoto","year":"1996","unstructured":"Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T, Hirohata T (1996) Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochir 138(4):390\u2013395","journal-title":"Acta Neurochir"},{"issue":"3\u20134","key":"7_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2152\/jmi.52.151","volume":"52","author":"W Liu","year":"2005","unstructured":"Liu W, Matsumoto Y, Okada M, Miyake K, Kunishio K, Kawai N et al (2005) Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. J Med Investig 52(3\u20134):151\u2013158","journal-title":"J Med Investig"},{"issue":"4","key":"7_CR48","first-page":"3556","volume":"8","author":"P Hui","year":"2015","unstructured":"Hui P, Xu X, Xu L, Hui G, Wu S, Lan Q (2015) Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis. Int J Clin Exp Pathol 8(4):3556\u20133567","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"7_CR49","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.humpath.2009.10.023","volume":"41","author":"X Qu","year":"2010","unstructured":"Qu X, Yang W, Jiang M, Han T, Han L, Qu Y et al (2010) CD147 expression in pituitary adenomas and its significance for clinical outcome. Hum Pathol 41(8):1165\u20131171","journal-title":"Hum Pathol"},{"issue":"6","key":"7_CR50","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/00006123-199912000-00033","volume":"45","author":"E Beaulieu","year":"1999","unstructured":"Beaulieu E, Kachra Z, Mousseau N, Delbecchi L, Hardy J, Beliveau R (1999) Matrix metalloproteinases and their inhibitors in human pituitary tumors. Neurosurgery 45(6):1432\u20131440. discussion 40-1","journal-title":"Neurosurgery"},{"issue":"2","key":"7_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11060-008-9606-5","volume":"89","author":"D Yoshida","year":"2008","unstructured":"Yoshida D, Nomura R, Teramoto A (2008) Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). J Neuro-Oncol 89(2):141\u2013150","journal-title":"J Neuro-Oncol"},{"issue":"17","key":"7_CR52","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.1074\/jbc.271.17.10079","volume":"271","author":"JM Whitelock","year":"1996","unstructured":"Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271(17):10079\u201310086","journal-title":"J Biol Chem"},{"issue":"3","key":"7_CR53","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1530\/JOE-15-0451","volume":"228","author":"MV Recouvreux","year":"2016","unstructured":"Recouvreux MV, Camilletti MA, Rifkin DB, Diaz-Torga G (2016) The pituitary TGFbeta1 system as a novel target for the treatment of resistant prolactinomas. J Endocrinol 228(3):R73\u2013R83","journal-title":"J Endocrinol"},{"issue":"3","key":"7_CR54","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11102-011-0292-5","volume":"14","author":"L Qiu","year":"2011","unstructured":"Qiu L, He D, Fan X, Li Z, Liao C, Zhu Y et al (2011) The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas. Pituitary 14(3):266\u2013275","journal-title":"Pituitary"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.biopha.2017.11.034","volume":"97","author":"J Wang","year":"2018","unstructured":"Wang J, Zhang Z, Li R, Mao F, Sun W, Chen J et al (2018) ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR\/ERK signaling pathway. Biomed Pharmacother 97:1066\u20131077","journal-title":"Biomed Pharmacother"},{"key":"7_CR56","doi-asserted-by":"crossref","unstructured":"Liu KW, Pajtler KW, Worst BC, Pfister SM, Wechsler-Reya RJ (2017) Molecular mechanisms and therapeutic targets in pediatric brain tumors. Sci Signal 10(470)","DOI":"10.1126\/scisignal.aaf7593"},{"issue":"3","key":"7_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00428-006-0351-x","volume":"450","author":"SA Mucha","year":"2007","unstructured":"Mucha SA, Melen-Mucha G, Godlewski A, Stepien H (2007) Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat. Virchows Arch 450(3):335\u2013341","journal-title":"Virchows Arch"},{"issue":"1","key":"7_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.2910150116","volume":"15","author":"RL Gross","year":"1975","unstructured":"Gross RL, Steel CM, Levin AG, Singh S, Brubaker G (1975) In vitro immunological studies on east african cancer patients. III. Spontaneous rosette formation by cells from Burkitt lymphoma biopsies. Int J Cancer 15(1):139\u2013143","journal-title":"Int J Cancer"},{"issue":"6","key":"7_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/1523-1747.ep12524301","volume":"75","author":"M David","year":"1980","unstructured":"David M, Shohat B, Hazaz B, Feuerman EJ, Joshua H (1980) Identification of T & B lymphocytes on skin sections from patients with lymphoproliferative disorders of the skin. J Invest Dermatol 75(6):491\u2013494","journal-title":"J Invest Dermatol"},{"issue":"4","key":"7_CR60","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH et al (2018) The immune landscape of Cancer. Immunity 48(4):812\u2013830. e14","journal-title":"Immunity"},{"issue":"3","key":"7_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","volume":"26","author":"JQ Lu","year":"2015","unstructured":"Lu JQ, Adam B, Jack AS, Lam A, Broad RW, Chik CL (2015) Immune cell infiltrates in pituitary adenomas: more macrophages in larger adenomas and more T cells in growth hormone adenomas. Endocr Pathol 26(3):263\u2013272","journal-title":"Endocr Pathol"},{"key":"7_CR62","doi-asserted-by":"crossref","unstructured":"Barry S, Carlsen E, Marques P, Stiles CE, Gadaleta E, Berney DM, et al (2019) Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors. Oncogene","DOI":"10.1038\/s41388-019-0779-5"},{"issue":"1","key":"7_CR63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1210\/jc.2009-1583","volume":"95","author":"I Lupi","year":"2010","unstructured":"Lupi I, Manetti L, Caturegli P, Menicagli M, Cosottini M, Iannelli A et al (2010) Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab 95(1):289\u2013296","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7_CR64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12020-017-1289-2","volume":"58","author":"L Brilli","year":"2017","unstructured":"Brilli L, Danielli R, Ciuoli C, Calabro L, Di Giacomo AM, Cerase A et al (2017) Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab. Endocrine 58(3):535\u2013541","journal-title":"Endocrine"},{"issue":"9","key":"7_CR65","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1210\/jc.2005-2671","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G et al (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91(9):3316\u20133323","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239\u2013277","journal-title":"Endocr Rev"},{"issue":"6","key":"7_CR67","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1586\/17446651.2.6.725","volume":"2","author":"AF Daly","year":"2007","unstructured":"Daly AF, Vanbellinghen JF, Beckers A (2007) Characteristics of familial isolated pituitary adenomas. Expert Rev Endocrinol Metab 2(6):725\u2013733","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"6","key":"7_CR68","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1210\/jc.2007-2611","volume":"93","author":"CA Leontiou","year":"2008","unstructured":"Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S et al (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93(6):2390\u20132401","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"7_CR69","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2016-1307","volume":"101","author":"LC Hernandez-Ramirez","year":"2016","unstructured":"Hernandez-Ramirez LC, Martucci F, Morgan RM, Trivellin G, Tilley D, Ramos-Guajardo N et al (2016) Rapid proteasomal degradation of mutant proteins is the primary mechanism leading to tumorigenesis in patients with missense AIP mutations. J Clin Endocrinol Metab 101(8):3144\u20133154","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7_CR70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/EJE-17-0293","volume":"177","author":"R Salvatori","year":"2017","unstructured":"Salvatori R, Radian S, Diekmann Y, Iacovazzo D, David A, Gabrovska P et al (2017) In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism. Eur J Endocrinol 177(3):257\u2013266","journal-title":"Eur J Endocrinol"},{"issue":"25","key":"7_CR71","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO et al (2014) Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371(25):2363\u20132374","journal-title":"N Engl J Med"},{"issue":"3","key":"7_CR72","first-page":"1262","volume":"87","author":"X Zhang","year":"2002","unstructured":"Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B et al (2002) Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87(3):1262\u20131267","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7_CR73","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1210\/jc.2003-030222","volume":"88","author":"X Zhang","year":"2003","unstructured":"Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR et al (2003) A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 88(11):5119\u20135126","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR74","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/path.1700910208","volume":"91","author":"LW Duchen","year":"1966","unstructured":"Duchen LW (1966) Metastatic carcinoma in the pituitary gland and hypothalamus. J Pathol Bacteriol 91(2):347\u2013355","journal-title":"J Pathol Bacteriol"},{"issue":"2","key":"7_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol 156(2):203\u2013216","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"7_CR76","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.1979.03630460043015","volume":"139","author":"HY Yap","year":"1979","unstructured":"Yap HY, Tashima CK, Blumenschein GR, Eckles N (1979) Diabetes insipidus and breast cancer. Arch Intern Med 139(9):1009\u20131011","journal-title":"Arch Intern Med"},{"issue":"1","key":"7_CR77","first-page":"64","volume":"75","author":"I Hagerstrand","year":"1969","unstructured":"Hagerstrand I, Schonebeck J (1969) Metastases to the pituitary gland. Acta Pathol Microbiol Scand 75(1):64\u201370","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"1","key":"7_CR78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11102-014-0552-2","volume":"18","author":"W He","year":"2015","unstructured":"He W, Chen F, Dalm B, Kirby PA, Greenlee JD (2015) Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary 18(1):159\u2013168","journal-title":"Pituitary"},{"issue":"2","key":"7_CR79","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1210\/jc.2003-030395","volume":"89","author":"J Komninos","year":"2004","unstructured":"Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE et al (2004) Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89(2):574\u2013580","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3171\/jns.1998.89.1.0069","volume":"89","author":"A Morita","year":"1998","unstructured":"Morita A, Meyer FB, Laws ER Jr (1998) Symptomatic pituitary metastases. J Neurosurg 89(1):69\u201373","journal-title":"J Neurosurg"},{"issue":"1","key":"7_CR81","first-page":"51","volume":"36","author":"A Ruelle","year":"1992","unstructured":"Ruelle A, Palladino M, Andrioli GC (1992) Pituitary metastases as presenting lesions of malignancy. J Neurosurg Sci 36(1):51\u201354","journal-title":"J Neurosurg Sci"},{"key":"7_CR82","doi-asserted-by":"crossref","unstructured":"Cai H, Liu W, Feng T, Li Z, Liu Y (2019) Clinical presentation and pathologic characteristics of pituitary metastasis from breast carcinoma: cases and a systematic review of the literature. World Neurosurg","DOI":"10.1016\/j.wneu.2018.12.126"},{"issue":"10","key":"7_CR83","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0025-6196(12)60925-2","volume":"67","author":"F Marin","year":"1992","unstructured":"Marin F, Kovacs KT, Scheithauer BW, Young WF Jr (1992) The pituitary gland in patients with breast carcinoma: a histologic and immunocytochemical study of 125 cases. Mayo Clin Proc 67(10):949\u2013956","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"7_CR84","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12020-012-9806-9","volume":"43","author":"D Barbaro","year":"2013","unstructured":"Barbaro D, Desogus N, Boni G (2013) Pituitary metastasis of thyroid cancer. Endocrine 43(3):485\u2013493","journal-title":"Endocrine"},{"issue":"7","key":"7_CR85","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1634\/theoncologist.12-7-884","volume":"12","author":"AF Eichler","year":"2007","unstructured":"Eichler AF, Loeffler JS (2007) Multidisciplinary management of brain metastases. Oncologist 12(7):884\u2013898","journal-title":"Oncologist"},{"issue":"2","key":"7_CR86","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3340\/jkns.2013.54.2.132","volume":"54","author":"JM Hwang","year":"2013","unstructured":"Hwang JM, Kim YH, Kim TM, Park SH (2013) Differential diagnosis and management of a pituitary mass with renal cell carcinoma. J Korean Neurosurg Soc 54(2):132\u2013135","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"7_CR87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/02688698909001028","volume":"3","author":"PC McCormick","year":"1989","unstructured":"McCormick PC, Post KD, Kandji AD, Hays AP (1989) Metastatic carcinoma to the pituitary gland. Br J Neurosurg 3(1):71\u201379","journal-title":"Br J Neurosurg"},{"issue":"6","key":"7_CR88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","volume":"29","author":"RA Patchell","year":"2003","unstructured":"Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29(6):533\u2013540","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"7_CR89","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/1097-0142(197009)26:3<656::AID-CNCR2820260325>3.0.CO;2-M","volume":"26","author":"WA Houck","year":"1970","unstructured":"Houck WA, Olson KB, Horton J (1970) Clinical features of tumor metastasis to the pituitary. Cancer 26(3):656\u2013659","journal-title":"Cancer"},{"issue":"1","key":"7_CR90","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/BF02409058","volume":"3","author":"P Sioutos","year":"1996","unstructured":"Sioutos P, Yen V, Arbit E (1996) Pituitary gland metastases. Ann Surg Oncol 3(1):94\u201399","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7_CR91","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3171\/2014.12.JNS14870","volume":"123","author":"M Habu","year":"2015","unstructured":"Habu M, Tokimura H, Hirano H, Yasuda S, Nagatomo Y, Iwai Y et al (2015) Pituitary metastases: current practice in Japan. J Neurosurg 123(4):998\u20131007","journal-title":"J Neurosurg"},{"issue":"4","key":"7_CR92","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3171\/2008.9.JNS08397","volume":"110","author":"JQ Lu","year":"2009","unstructured":"Lu JQ, Khalil M, Hu W, Sutherland GR, Clark AW (2009) Tumor-to-tumor metastasis: esophageal carcinoma metastatic to an intracranial paraganglioma. J Neurosurg 110(4):744\u2013748","journal-title":"J Neurosurg"},{"issue":"5","key":"7_CR93","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0090-3019(01)00447-5","volume":"55","author":"P Bret","year":"2001","unstructured":"Bret P, Jouvet A, Madarassy G, Guyotat J, Trouillas J (2001) Visceral cancer metastasis to pituitary adenoma: report of two cases. Surg Neurol 55(5):284\u2013290","journal-title":"Surg Neurol"},{"issue":"12","key":"7_CR94","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1136\/jcp.53.12.946","volume":"53","author":"F Fraggetta","year":"2000","unstructured":"Fraggetta F, Galia A, Grasso G, D'Arrigo C, Cristaudo C, Giangaspero F (2000) Pulmonary adenocarcinoma metastatic to pituitary craniopharyngioma. J Clin Pathol 53(12):946\u2013947","journal-title":"J Clin Pathol"},{"issue":"1","key":"7_CR95","first-page":"69","volume":"92","author":"JA Ramsay","year":"1988","unstructured":"Ramsay JA, Kovacs K, Scheithauer BW, Ezrin C, Weiss MH (1988) Metastatic carcinoma to pituitary adenomas: a report of two cases. Exp Clin Endocrinol 92(1):69\u201376","journal-title":"Exp Clin Endocrinol"},{"issue":"4","key":"7_CR96","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535","journal-title":"Acta Neuropathol"},{"issue":"3","key":"7_CR97","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1507\/endocrj.45.357","volume":"45","author":"HM Heshmati","year":"1998","unstructured":"Heshmati HM, Kujas M, Casanova S, Wollan PC, Racadot J, Van Effenterre R et al (1998) Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr J 45(3):357\u2013361","journal-title":"Endocr J"},{"issue":"9","key":"7_CR98","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1073\/pnas.0902599107","volume":"107","author":"C Lafont","year":"2010","unstructured":"Lafont C, Desarmenien MG, Cassou M, Molino F, Lecoq J, Hodson D et al (2010) Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Natl Acad Sci U S A 107(9):4465\u20134470","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"7103720","DOI":"10.1155\/2016\/7103720","volume":"2016","author":"K Megnis","year":"2016","unstructured":"Megnis K, Mandrika I, Petrovska R, Stukens J, Rovite V, Balcere I et al (2016) Functional characteristics of multipotent mesenchymal stromal cells from pituitary adenomas. Stem Cells Int 2016:7103720","journal-title":"Stem Cells Int"},{"issue":"47","key":"7_CR100","doi-asserted-by":"publisher","first-page":"76565","DOI":"10.18632\/oncotarget.12088","volume":"7","author":"Y Mei","year":"2016","unstructured":"Mei Y, Bi WL, Greenwald NF, Du Z, Agar NY, Kaiser UB et al (2016) Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget 7(47):76565\u201376576","journal-title":"Oncotarget"},{"issue":"1","key":"7_CR101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-018-2844-2","volume":"139","author":"PF Wang","year":"2018","unstructured":"Wang PF, Wang TJ, Yang YK, Yao K, Li Z, Li YM et al (2018) The expression profile of PD-L1 and CD8(+) lymphocyte in pituitary adenomas indicating for immunotherapy. J Neuro-Oncol 139(1):89\u201395","journal-title":"J Neuro-Oncol"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironments in Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-59038-3_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:08:24Z","timestamp":1624979304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-59038-3_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030590376","9783030590383"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-59038-3_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"30 June 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}